Recent considerations in nonsteroidal anti-inflammatory drug gastropathy (Q46924071)

26 December 2017

review article

1 reference

title

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy (English)

1 reference

26 December 2017

0 references

G Singh

1

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

26 December 2017

American Journal of Medicine

published in

1 reference

26 December 2017

volume

105

1 reference

26 December 2017

page(s)

31S-38S

1 reference

26 December 2017

issue

1B

1 reference

26 December 2017

A reevaluation of aspirin therapy in rheumatoid arthritis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Measurement of patient outcome in arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Nonsteroidal antiinflammatory drugs--differences and similarities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Gastroscopic evaluation of anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Effects of fenbufen, indomethacin, naproxen, and placebo on gastric mucosa of normal volunteers. A comparative endoscopic and photographic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

A toxicity index for comparison of side effects among different drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

The relative toxicity of disease-modifying antirheumatic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Comparative toxicity of non-steroidal anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

The relative toxicity of nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900072-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(98)00072-2

1 reference

26 December 2017

PubMed ID

9715832

1 reference

26 December 2017